ID   5821c3
AC   CVCL_YM19
DR   Wikidata; Q93307874
RX   PubMed=29958801;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: KrasLSL-G12D/+;Trp53LSL-R172H/+;Pdx1-Cre;Rosa26YFP/YFP (KPCY).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 5
//
RX   PubMed=29958801; DOI=10.1016/j.immuni.2018.06.006; PMCID=PMC6707727;
RA   Li J.-Y., Byrne K.T., Yan F.-X., Yamazoe T., Chen Z.-Y., Baslan T.,
RA   Richman L.P., Lin J.H., Sun Y.H., Rech A.J., Balli D., Hay C.A.,
RA   Sela Y., Merrell A.J., Liudahl S.M., Gordon N., Norgard R.J., Yuan S.,
RA   Yu S.-X., Chao T., Ye S., Eisinger-Mathason T.S.K., Faryabi R.B.,
RA   Tobias J.W., Lowe S.W., Coussens L.M., Wherry E.J. 3rd,
RA   Vonderheide R.H., Stanger B.Z.;
RT   "Tumor cell-intrinsic factors underlie heterogeneity of immune cell
RT   infiltration and response to immunotherapy.";
RL   Immunity 49:178-193.e7(2018).
//